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The CD4
 
  
 
CD25
 
  
 
regulatory T cells play a critical role in controlling autoimmunity, but little 
is known about their development and maintenance. In this study, we investigated whether 
CD4
 
  
 
CD25
 
  
 
cells can convert to CD4
 
  
 
CD25
 
  
 
regulatory T cells in vivo under natural 
conditions. CD4
 
  
 
CD25
 
  
 
cells from CD45.1
 
  
 
mice were sorted and transferred into congenic 
CD45.2
 
  
 
mice. Converted CD4
 
  
 
CD25
 
  
 
cells could be detected in lymphoid organs as early as 
1 wk after transfer and by 6 wk after transfer, 5–12% of transferred CD4
 
  
 
cells expressed 
CD25. Converted CD4
 
  
 
CD25
 
  
 
cells themselves failed to proliferate after stimulation, but 
could suppress proliferation of responder cells in vitro, and also expressed high levels of 
Foxp3 mRNA. In addition, CD4
 
  
 
CD25
 
  
 
cells transferred into thymectomized congenic mice 
converted to CD4
 
  
 
CD25
 
  
 
cells that also suppressed responder cell proliferation in vitro, and 
expressed high levels of Foxp3 mRNA. Finally, CD4
 
  
 
CD25
 
  
 
cells transferred into B7
 
 
 
/
 
  
 
mice 
failed to convert into CD4
 
  
 
CD25
 
  
 
cells that exhibit the regulatory phenotype. These data 
indicate that CD4
 
  
 
CD25
 
  
 
cells convert into CD4
 
  
 
CD25
 
  
 
regulatory T cells spontaneously in 
vivo and suggest that this conversion process could contribute significantly to the 
maintenance of the peripheral CD4
 
  
 
CD25
 
  
 
regulatory T cell population.
 
Regulating potentially autoreactive cells that
have escaped negative selection in the thymus
is an important function of peripheral toler-
ance. A growing body of evidence suggests
that a population of regulatory T cells, CD4
 
 
 
CD25
 
  
 
T cells, first identified by Asano et al.
(1) and Sakaguchi et al. (2), is critical for con-
trolling a wide variety of immune responses in-
cluding those that cause many types of autoim-
mune disease. Depletion of this population of
cells results in multi-organ autoimmune diseases
in a variety of strains of mice (1, 2). It is still
unclear to date whether the CD4
 
  
 
CD25
 
  
 
reg-
ulatory T cell population represents a distinct
lineage of T cells. Several lines of evidence
suggest that these cells develop in the thymus.
For example, CD4
 
  
 
(CD8
 
 
 
) CD25
 
  
 
T cells
can be found in the thymus and exhibit phe-
notypic and functional characteristics that are
identical to those found in peripheral CD4
 
 
 
CD25
 
  
 
T cells. Adoptive transfer of this popu-
lation of thymocytes prevents development of a
variety of autoimmune and inflammatory diseases
(3). Furthermore, CD4
 
  
 
CD25
 
  
 
T cells develop
directly in fetal thymic organ cultures (3).
These cells appear to be positively selected on
thymic epithelium because mice that do not
express MHC class II on their thymic cortical
epithelium fail to develop CD4
 
  
 
CD25
 
  
 
regu-
latory T cells, and transgenic mice that express
specific peptide on their thymic stromal cells
produce extremely high percentages of CD4
 
 
 
CD25
 
  
 
regulatory T cells (4, 5). Although it
appears very likely that most CD4
 
  
 
CD25
 
 
 
regulatory T cell development occurs in the
thymus, accumulating evidence suggests that
these cells may also develop in the periphery
(i.e., extrathymically). For example, although
under normal circumstances all CD4
 
  
 
cells from
RAG
 
 
 
/
 
  
 
TCR transgenic mice are CD25
 
 
 
,
studies have shown that a percentage of
RAG
 
 
 
/
 
  
 
TCR transgenic T cells adoptively
transferred into antigen-expressing transgenic
mice or mice that have received a tolerizing
dose of peptide antigen administered either i.v.
or orally can convert to a CD4
 
  
 
CD25
 
  
 
regu-
latory T cell phenotype (6, 7). It is unclear,
however, whether CD4
 
  
 
CD25
 
  
 
T cells can or
do convert to a CD4
 
  
 
CD25
 
  
 
regulatory T cell
phenotype under natural conditions, i.e., with
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expression of the natural TCR repertoire and exposure to the
natural endogenous antigen load. The purpose of this study
was to address this issue and identify the requirements for this
conversion process. We have found that mature peripheral
CD4
 
  
 
CD25
 
  
 
T cells can indeed convert to a CD4
 
  
 
CD25
 
 
 
regulatory T cell phenotype and do so in a thymus-indepen-
dent but B7-dependent manner.
 
RESULTS
CD4
 
  
 
CD25
 
  
 
T cells can convert into CD4
 
  
 
CD25
 
  
 
T cells in 
vivo in both sublethally irradiated and nonirradiated mice
 
It is not clear whether the CD4
 
  
 
CD25
 
  
 
T cells represent a
distinct lineage of cells that develops exclusively in the thy-
mus or whether these cells can be induced in the periphery.
The following experiments were designed to determine
whether CD4
 
  
 
CD25
 
  
 
T cells from wild-type mice are capa-
ble of converting to a CD4
 
  
 
CD25
 
  
 
regulatory T cell pheno-
type in vivo. LN and spleen cells were harvested from con-
genic CD45.1
 
  
 
mice and CD4
 
  
 
CD25
 
  
 
T cells were sorted
to 
 
 
 
99.7% purity (Fig. 1 A). 10 
 
  
 
10
 
6 
 
CD45.1
 
  
 
CD4
 
 
 
CD25
 
  
 
T cells were injected i.v. into sublethally irradiated
CD45.2
 
  
 
mice. Blood was collected weekly and LN, spleen,
and thymus were harvested either 1 or 6 wk after injection of
cells. Donor CD45.1
 
  
 
CD4
 
  
 
cells were gated (Fig. 1 B, left)
and analyzed for the presence of CD45.1
 
  
 
CD4
 
  
 
CD25
 
  
 
T
cells. The CD45.1
 
  
 
CD4
 
  
 
CD25
 
  
 
T cells (2–4%) could be
detected in blood (not depicted), LN (Fig. 1 B, middle), and
spleen (see Fig. S1, middle, which is available at http://
www.jem.org/cgi/content/full/jem.20041201/DC1), but
not thymus (not depicted), as early as 1 wk after i.v. injection
of CD45.1
 
  
 
CD4
 
  
 
CD25
 
  
 
T cells. By 6 wk after injection,
5–12% of the transferred CD45.1
 
  
 
cells expressed CD25 in
LN (Fig. 1 B, right) as well as in the thymus (not depicted).
The percentage of CD25
 
  
 
cells in the spleen was somewhat
less and averaged 
 
 
 
5–7% (Fig. S1, right).
Sublethal levels of irradiation create significant “space” in
the immune compartment and induce T cells to undergo dra-
matic homeostatic proliferation to fill this space. There is,
therefore, a possibility that the CD4
 
  
 
CD25
 
  
 
cells introduced
to this environment may up-regulate CD25 as a consequence
Figure 1. CD4  CD25  cells convert into CD4  CD25  cells that ex-
hibit regulatory function in sublethally irradiated mice. (A) Purity of 
CD4  CD25  cells for transfer. CD4  CD25  cells from LN and spleen cells 
of CD45.1  mice were purified using T and CD4 cell affinity columns, mag-
netic beads, and high speed sorting. CD4  CD25  cells account for  10% 
of CD4  cells before sorting (left). CD4  CD25  cells were purified to 
 99.7% ( 0.3% contamination with CD4  CD25  cells; right). (B) 10   106 
million purified CD45.1  CD4  CD25  cells were transferred into sub-
lethally irradiated CD45.2  recipients. (B) LN cells or (C and D) LN and spleen 
cells were collected and labeled for CD45.1, CD4, and CD25. CD45.1  CD4  
cells (B) were gated and analyzed for the presence of converted CD4  
CD25  cells 1 (middle) and 6 wk (right) after transfer or 6 wk after transfer 
and were (C) tested for regulatory function or (D) Foxp3 expression. (C) To 
test for regulatory function, 25,000 freshly harvested CD4  CD25  cells 
(Responder cells) were purified and cocultured at a 1:1 (regulatory/responder) 
ratio with either freshly harvested CD4  CD25  cells (Control) or sorted 
CD45.1  CD4  CD25  cells (Converted) in the presence of irradiated spleen 
cells (APCs) and anti-CD3 for 3 d. (D) For quantitative analysis of Foxp3 
expression, freshly harvested CD4  CD25  (Control) or CD4  CD25  (Con-
trol) cells, or CD45.1  CD4  CD25  (Transferred) or CD45.1  CD4  CD25  
(Converted) cells were sorted and Foxp3 mRNA levels were quantified by 
real-time PCR. Data are presented as normalized Foxp3 mRNA expression 
levels in the samples relative to normalized Foxp3 mRNA expression levels 
in the control CD4  CD25  cells (fold change   1). *, a significant differ-
ence from the positive control (P   0.01).JEM VOL. 201, January 3, 2005 129
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of this homeostatic proliferation. To determine whether the
conversion of CD4  CD25  cells into CD4  CD25  cells can
occur in the absence of the homeostatic proliferation found in
the sublethally irradiated (lymphopenic) mice, CD45.1  CD4 
CD25  T cells were injected into normal nonirradiated
CD45.2  recipients. The percentage (and numbers) of total
CD45.1  CD4  cells recovered from all of the lymphoid or-
gans 6 wk later was extremely low by comparison to sublethally
irradiated animals (sublethally irradiated:  12% vs. nonirradi-
ated:  0.5%). Despite the scarcity of the transferred CD45.1 
cells, the relative percentage of CD4  CD25  cells found in
nonirradiated mice was similar to that found in sublethally irra-
diated mice. In nonirradiated mice, 7–12% of transferred cells
expressed CD25 in the LN (Fig. 2 A, right), and 4–7% of trans-
ferred cells expressed CD25 in the spleen (not depicted). Trans-
ferred CD45.1  CD4  cells were virtually undetectable in the
thymus of these mice. Based on these results, it appears that
CD4  CD25  cells can convert to a CD25  phenotype
whether the cells are transferred into a lymphopenic environ-
ment and subsequently undergo homeostatic proliferation, or
whether they are transferred into a “normal” environment
where they undergo very limited homeostatic proliferation.
Converted CD4  CD25 , but not transferred CD4  CD25 , 
T cells exhibit characteristics of the naturally occurring 
CD4  CD25  regulatory T cells
Because CD25, the IL-2R  chain, is an activation marker for
T cells as well as a marker for a population of naturally occur-
ring regulatory T cells (2), the up-regulation of CD25 on a
small percentage of initially CD4  CD25  cells could con-
ceivably be the result of activation of these cells after injec-
tion. The CD4  CD25  regulatory T cells are characterized
by their failure to proliferate in response to stimulation in
vitro (anergy), their ability to suppress responder T cell
(CD4  CD25  T cell) proliferation in vitro, high levels of
Foxp3 expression, and expression of an array of typical surface
markers (8–17). The following series of experiments were de-
signed to determine whether the converted CD4  CD25  T
cells exhibit the same characteristics as naturally occurring
CD4   CD25   regulatory T cells. For these experiments,
CD45.1  CD4  CD25  T cells were injected into either sub-
lethally irradiated or nonirradiated CD45.2  mice. After 6
wk, LNs and spleens were harvested from CD45.2  mice that
had received CD45.1  CD4  CD25  T cells, and the con-
verted CD45.1  CD4  CD25  cells and CD45.1  CD4 
CD25  cells were sorted. For the functional assays, converted
CD45.1  CD4  CD25  cells stimulated in vitro in the pres-
ence of irradiated spleen cells as APCs and anti-CD3 did not
proliferate; i.e., these cells were anergic (Fig. S2 A, available at
http://www.jem.org/cgi/content/full/jem.20041201/DC1),
whereas transferred CD45.1  CD4  CD25  T cells that did
not convert to a CD25  phenotype proliferated readily in re-
sponse to stimulation in vitro (Fig. S2 B). In a standard assay
for the analysis of in vitro regulatory activity, converted
CD45.1  CD4  CD25  T cells from both sublethally irradi-
ated and nonirradiated mice T cells suppressed proliferation of
Figure 2. CD4  CD25  cells convert into CD4  CD25  cells that ex-
hibit regulatory function in nonirradiated mice. 10   106 purified 
CD45.1  CD4  CD25  cells were transferred into nonirradiated CD45.2  
recipients and lymphoid cells collected 6 wk after transfer. LN cells were 
labeled for CD45.1, CD4, and CD25, and (A) CD45.1  CD4  cells were gated 
and then analyzed for the presence of converted CD4  CD25  cells or (B) 
CD45.1  CD4  CD25  cells were sorted and tested for regulatory function. 
10   106 purified CD45.1  CD4  CD25  cells were also labeled with CFSE 
and then transferred into nonirradiated CD45.2  recipients. 1 wk after 
transfer, lymphoid cells were collected and (C) CD45.1  CD4  cells were 
analyzed for the presence of CFSEhi CD25  cells or (D) pooled and CFSEhi 
CD45.1  CD4  CD25  cells sorted by high speed sorter and tested for reg-
ulatory function in vitro. To test for regulatory function, 12,000 freshly 
harvested CD4  CD25  cells (Responder cells) were purified and cocul-
tured at a 1:4 (regulatory/responder) ratio with either freshly harvested 
CD4  CD25  cells (Control) or (B) CD45.1  CD4  CD25  cells (Converted), 
or (D) CFSEhi CD45.1  CD4  CD25  cells (CFSEhi) in the presence of irradi-
ated spleen cells (APC) and anti-CD3 for 3 d. *, a significant difference 
from the positive control (P   0.01).CD4  CD25  CELLS CONVERT INTO CD4  CD25  REGULATORY T CELLS IN VIVO | Liang et al. 130
responder cells (Figs. 1 C and 2 B, respectively), whereas
CD45.1  CD4  CD25  T cells did not (not depicted).
Naturally occurring CD4  CD25  regulatory cells that
have undergone homeostatic proliferation in vivo exhibit
more potent regulatory function in in vitro assays (18). To
determine whether transferred cells that have undergone ho-
meostatic proliferation can convert and exhibit more potent
regulatory function, purified CD45.1  CD4  CD25  cells
were labeled with carboxyfluorescein diacetate succinimidyl
ester (CFSE) and transferred into sublethally irradiated
CD45.2  recipients. 6 wk later, converted CFSElo CD45.1 
CD4  CD25  cells (i.e., cells that had undergone homeo-
static division; Fig. 3 A) were sorted and tested for their abil-
ity to suppress at various regulatory/responder cell ratios.
Converted CD45.1  CD4  CD25  cells that had undergone
homeostatic proliferation were much more effective at sup-
pressing responder proliferative responses at lower regula-
tory/responder cell ratios than freshly harvested control
CD4  CD25  regulatory T cells, indicating that these con-
verted cells possess greater regulatory capacity (Fig. 3 B). In
the next experiment, converted CD4  CD25  T cells were
tested for the possibility that they mediate suppression in vitro
through the production of the immunosuppressive cytokines,
TGF  and IL-10 (19–22). Similar to what some investigators
have reported for naturally occurring CD4  CD25  regula-
tory T cells, converted CD4  CD25  T cells from either
nonirradiated (Fig. 4, A and B) or sublethally irradiated (not
depicted) mice do not suppress responder cell proliferation in
vitro through the production of either TGF  or IL-10 (Fig.
4, A and B, respectively). This was found using either 10 or
50  g/ml of antibody (not depicted).
In the next test for the CD4  CD25  regulatory T cell
phenotype, expression of the transcription factor, Foxp3,
was analyzed by real-time PCR in sorted converted CD45.1 
CD4  CD25  T cells and in transferred CD45.1  CD4 
CD25  T cells that did not convert to a CD25  phenotype.
Converted CD45.1  CD4  CD25 , but not CD45.1  CD4 
CD25 , T cells expressed high levels of Foxp3 mRNA that
were comparable to control CD4  CD25  regulatory T cells
(Fig. 1 D).
The final experiment in this series examined whether
converted CD4   CD25   cells express the typical surface
markers that are associated with naturally occurring CD4 
CD25   regulatory cells. Although glucocorticoid-induced
TNF receptor gene (GITR) and cytotoxic T lymphocyte–
associated antigen 4 (CTLA-4) are also expressed by activated
T cells, they are expressed at constitutively high levels by nat-
urally occurring CD4  CD25  regulatory T cells and appear
to be involved at some level in the function of these cells
Figure 3. Converted CD4  CD25  cells that undergo homeostatic 
proliferation exhibit more potent regulatory function in vitro than 
freshly harvested CD4  CD25  cells. 10   106 purified CD45.1  CD4  
CD25  cells were labeled with CFSE and then transferred into sublethally 
irradiated CD45.2  recipients. 6 wk after transfer, LN and spleen cells were 
collected, pooled, and (A) CFSElo CD45.1  CD4  CD25  cells were sorted by 
high speed sorter and (B) tested for regulatory function in vitro. For this 
assay, 25,000 freshly harvested CD4  CD25  cells (Responder cells) were 
purified and cocultured at varying (regulatory/responder) ratios with either 
freshly harvested CD4  CD25  cells (Control) or CFSElo CD45.1  CD4  
CD25  cells (Converted) in the presence of irradiated spleen cells (APC) 
and anti-CD3 for 3 d.
Figure 4. Converted CD4  CD25  cells do not suppress responder 
cell proliferation through the production of TGF  or IL-10. 10   106 
purified CD45.1  CD4  CD25  cells were transferred into nonirradiated 
CD45.2  recipients. 6 wk after transfer, lymphoid cells were collected, 
pooled, and CD45.1  CD4  CD25  cells were sorted by high speed sorter 
and tested for regulatory function in vitro. For this assay, 12,000 freshly 
harvested CD4  CD25  cells (Responder cells) were purified and cocultured 
at a 1:4 (regulatory/responder) ratio with either freshly harvested CD4  
CD25  cells (Control) or CD45.1  CD4  CD25  cells (Converted) in the 
presence of irradiated spleen cells (APC) and either isotype, (A) anti-TGF , 
or (B) 10  g/ml anti–IL-10 antibodies and anti-CD3 for 3 d. *, a significant 
difference from the positive control (P   0.01).JEM VOL. 201, January 3, 2005 131
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(13–15, 17). Expression of high levels of either CD62L or
CD103 is associated with more potent suppressive function
in vitro (11, 16). CD45RBlo expression identifies another
population of regulatory T cells that controls colitis and may
overlap in function with the CD4  CD25  regulatory cells
(12). In the following experiments, expression of these
markers was compared between converted CD45.1  CD4 
CD25  cells and naturally occurring CD4  CD25  regula-
tory T cells. In general, converted CD4  CD25  T cells ex-
press all of the markers that are typically expressed by natu-
rally occurring CD4  CD25  regulatory T cells (Fig. 5). The
profiles were similar between the converted and naturally oc-
curring CD4  CD25  T cells. There were also no differences
in surface marker profiles between transferred and freshly har-
vested CD4  CD25  T cells (Fig. 5).
Taken together, these data strongly suggest that a per-
centage of CD4  CD25  T cells can be converted into
CD4  CD25  T cells that display function and phenotype
that are virtually indistinguishable from that of naturally oc-
curring CD4  CD25  regulatory T cells.
Conversion of CD4  CD25  cells into CD4  CD25  regulatory 
cells is not the result of expansion of residual CD4  CD25  
cells or selective CD4  CD25  cell survival
We have interpreted the appearance of CD4  CD25  cells af-
ter transfer of CD4  CD25  cells to indicate that conversion
had occurred. However, an alternative possibility is that the
tiny, almost undetectable ( 0.3% by FACS) population of
CD25  cells transferred along with the CD4  CD25  cells
could have expanded to give the appearance that the CD4 
CD25  cells had converted into CD4  CD25  cells. To ad-
dress this issue, sorted CD45.1  CD4  CD25  T cells were
labeled with CFSE and then injected into nonirradiated
CD45.2  mice to avoid homeostatic proliferation. After 1 wk,
CD45.1  CD4  CD25  cells that were CFSEhi (Fig. 2 C) and
had not undergone proliferation were sorted and tested for
their ability to suppress in vitro. Although only 2–4% of the
cells expressed CD25 (Fig. 2 C), these cells were able to sup-
press responder cell proliferation in vitro (Fig. 2 D). To further
address this issue, absolute numbers of recovered cells
(CD45.1 ) were analyzed 6 wk after transfer into nonirradi-
ated or sublethally irradiated mice. The purpose of the first
analysis was to determine the absolute number of CD4 
CD25  cells that could be recovered when known numbers of
CD4  CD25  cells were injected. 106, 100,000, or 30,000 pu-
rified conventional CD45.1  CD4  CD25  cells were injected
into nonirradiated mice (CD45.2 ), and then transferred cells
were analyzed 6 wk later. CD45.1  CD4  CD25  cells were
barely detectable ( 1,000) in mice that had received either
30,000 or 100,000 conventional CD45.1  CD4  CD25 
cells,  whereas 5,742   1,969 CD45.1  CD4  CD25  cells
(Table S1, available at http://www.jem.org/cgi/content/full/
Figure 5. Expression of surface markers GITR, CTLA-4, CD103, 
CD62L, and CD45RB is similar between converted and freshly har-
vested CD4  CD25  cells. 10   106 purified CD45.1  CD4  CD25  cells 
were transferred into sublethally irradiated CD45.2  recipients. 6 wk after 
transfer, lymphoid cells were collected and labeled for CD45.1, CD4, CD25, 
and either GITR, CTLA-4, CD103, CD62L, or CD45RB. Freshly harvested or 
converted CD45.1  CD4  CD25  or CD25  cells were gated and analyzed 
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jem.20041201/DC1) could be detected in mice that had re-
ceived 106 conventional CD45.1  CD4  CD25  cells. The
transferred CD4  CD25  cells could potentially contain 0.3%
contamination (refer to Fig. 1 A) of a trace population of
CD4  CD25  cells, which would equate to a total number of
 30,000 of the 10   106 CD4  CD25  cells injected. How-
ever, as many as 15,776   1,797 CD4  CD25  cells (Table
S1) could be recovered 6 wk after transfer of CD4  CD25 
cells, which, if we assume that the transferred CD4  CD25 
cell population consistently contains 30,000 CD4  CD25 
cells, would correspond to a  50% recovery of this trace pop-
ulation. This seems highly unlikely considering  1,000 or
only 3% of the 30,000 conventional CD4  CD25  cells that
were intentionally injected could be recovered 6 wk after
transfer. Similarly, in sublethally irradiated mice that received
106 conventional CD45.1  CD4  CD25  cells (i.e.,  30 times
the 30,000 trace CD4  CD25  population contaminating
the transferred CD4  CD25  cells), only 169,779   31,419
CD4  CD25  cells (i.e., 17% of the starting population or rep-
resenting a fivefold decrease) were recovered after 6 wk. On
the other hand, 442,173   49,106 CD4  CD25  cells (Table
S1) were recovered from mice that had received 10   106
CD4  CD25  cells 6 wk earlier, which would actually equate
to a 13-fold increase in the 30,000 CD4  CD25  cells con-
taminating the transferred CD4  CD25  population. Based on
the numbers described above, it would be impossible for the
progeny of a trace population of 30,000 CD4  CD25  cells to
expand to the numbers found 6 wk after transfer of CD45.1 
CD4  CD25  cells into either nonirradiated or sublethally ir-
radiated mice. The data presented in Table S1 also show that
CD4  CD25  cells (0.6% recovery in nonirradiated and 17%
recovery in irradiated mice) do not exhibit increased survival
over the CD4  CD25  cells (3.3% recovery in nonirradiated
and 80% recovery in irradiated mice) in these systems. There-
fore, these data also rule out selective survival of the CD4 
CD25  cells over the CD4  CD25  cells as a possible explana-
tion for the presence of these cells. In summary, the numerical
data described above strongly suggest that the appearance of
CD4  CD25  cells after transfer of CD4  CD25  cells was not
the result of expansion of a small contaminating population of
CD25  cells or selective survival of this trace population, but
could only be attributed to the actual conversion of the CD4 
CD25  T cells into CD4  CD25  regulatory T cells.
Conversion of CD4  CD25  T cells into functional CD4  
CD25  regulatory T cells does not require the thymus
The thymus is generally thought to be the site of CD4 
CD25  regulatory T cell development, and small numbers of
mature peripheral T cells can apparently recirculate back
through the thymus (23). There is, therefore, a possibility
that conversion of CD4  CD25  T cells to CD4  CD25 
regulatory T cells may occur in the thymus. The following
experiments were designed to test this possibility. Adult
CD45.2  mice were thymectomized, and 4 wk later, sorted
CD45.1  CD4  CD25  cells were injected into sublethally
or nonirradiated thymectomized mice. Blood was collected
weekly, and LN and spleen were harvested at 6 wk after in-
jection and analyzed for the presence of CD45.1  CD4 
CD25  T cells. CD45.1  CD4  CD25  T cells could be de-
tected in blood as early as 1–2 wk after injection (not de-
picted). In the sublethally irradiated thymectomized mice,
6–14% of the CD45.1  CD4  cells expressed CD25 in the
LN (Fig. 6 A) and 2–5% expressed CD25 in the spleen (not
depicted) 6 wk after transfer. Similar data were found in
nonirradiated thymectomized mice. Very few total CD45.1 
CD4  cells (sublethally irradiated:  25% vs. nonirradiated:
 1.5%) were recovered (similar to that found in nonirradi-
ated intact mice, see above), and of the CD45.1  cells that
were recovered, 7–11% of the CD45.1  CD4  cells in the
LN and 3–4% of the CD45.1  CD4  cells in the spleen ex-
pressed CD25 (not depicted). These data indicate that CD4 
CD25  cells can at least up-regulate CD25 in the absence of
the thymus in both sublethally and nonirradiated mice.
The next series of experiments was designed to determine
whether these cells that have converted to a CD25  pheno-
type in the absence of the thymus gland exhibit regulatory
function characteristic of naturally occurring CD4  CD25 
regulatory T cells. CD45.1  CD4  CD25  cells, but not
the unconverted CD45.1  CD4  CD25  cells (not depicted),
harvested from sublethally irradiated thymectomized mice
were able to suppress the proliferation of responder cells to the
same extent as the control CD4  CD25  regulatory T cells
(Fig. 6 B). Furthermore, CD45.1  CD4  CD25  cells, but
not CD45.1  CD4  CD25  cells, harvested from nonirradi-
Figure 6. CD4  CD25  cells can be converted in the absence of the 
thymus. 10   106 purified CD45.1  CD4  CD25  cells were transferred 
into thymectomized sublethally irradiated CD45.2  recipients. 6 wk after 
transfer, lymphoid cells were collected and either (A) labeled for CD45.1, 
CD4, and CD25, with CD45.1  CD4  cells gated and analyzed for the 
presence of converted CD4  CD25  cells, or (B) pooled and CD45.1  CD4  
CD25  sorted by high speed sorter and tested for regulatory function in 
vitro. For this assay, 25,000 freshly harvested CD4  CD25  cells (Responder 
cells) were purified and cocultured at a 1:1 (regulatory/responder) ratio 
with either freshly harvested CD4  CD25  cells (Control) or (B) CD45.1  
CD4  CD25  (Converted) cells in the presence of irradiated spleen cells 
(APC) and anti-CD3 for 3 d. *, a significant difference from the positive 
control (P   0.01).JEM VOL. 201, January 3, 2005 133
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ated thymectomized mice were also able to suppress the pro-
liferation of responder cells to the same extent as the control
CD4  CD25  regulatory T cells (not depicted). In the final
test for characteristics typical of CD4  CD25  regulatory T
cells, CD45.1  CD4  CD25  cells from sublethally irradiated
thymectomized mice were analyzed for expression of Foxp3.
Converted CD45.1  CD4  CD25  T cells, but not CD45.1 
CD4  CD25  cells, from thymectomized mice expressed high
levels of Foxp3 mRNA that were comparable to control
CD4  CD25  regulatory T cells (not depicted). Taken to-
gether, these data indicate that the conversion of CD4 
CD25  T cells into functional CD4  CD25  regulatory T
cells occurs in the periphery in the absence of the thymus.
Conversion of CD4  CD25  T cells into functional CD4  
CD25  regulatory T cells requires costimulation via B7.1/B7.2
Several reports have suggested that signaling through CD28
and/or CTLA-4 via B7.1/B7.2 is required for the develop-
ment and maintenance of CD4  CD25  regulatory T cells
(24–26). The following experiments were designed to deter-
mine whether costimulation via B7.1/B7.2 is required for
conversion of CD4  CD25  T cells into functional CD4 
CD25  regulatory T cells. For these experiments, CD45.1 
CD4   CD25   cells were injected into CD45.2   B7.1/
B7.2 /  mice. LN and spleen were harvested 6 wk after in-
jection and analyzed for the presence of converted CD45.1 
CD4  CD25  T cells. Very few CD45.1  CD4  cells were
recovered, and only 2–4% of the injected CD45.1  CD4  T
cells expressed CD25 compared with the 7–12% found in
B6 mice (Fig. 7 A, top, and B, left). Converted CD45.1 
CD4  CD25  T cells were sorted and tested for their ability
to suppress proliferation of responder cells in vitro. Sorted
CD45.1  CD4  CD25  T cells from B7.1/B7.2 /  mice
were unable to suppress the proliferation of responder cells 6
wk after transfer (Fig. 7 C).
Because CD28 costimulation via B7 is required for
CD4  CD25  regulatory cell homeostasis in the periphery
(24–26), it was necessary to rule out the possibility that the
CD4  CD25  cells could have converted to CD4  CD25 
cells initially (i.e., within the first week after transfer as found
in wild-type mice), but then failed to survive until collection
at 6 wk after transfer. Previous studies have found that
CD4  CD25  cells are dramatically decreased after 2 wk in
the absence of B7 costimulation (26). To determine
whether CD4  CD25  cells can survive for at least 1 wk in
the absence of B7 costimulation, 106 purified conventional
CD45.1  CD4  CD25  cells were transferred into either
wild-type B6 or B7.1/B7.2 /  mice. 1 wk later, absolute
numbers of CD45.1  CD4  CD25  cells were determined.
There were no significant differences between the absolute
numbers of CD45.1  CD4  CD25  cells recovered from
B6 (40,106   1,730) and B7.1/ B7.2 /  (47,450   9,879)
Figure 7. CD4  CD25  cells cannot be converted in the absence of 
B7 costimulation. 10   106 purified CD45.1  CD4  CD25  cells were 
transferred into nonirradiated wild-type (B6) or B7.1/B7.2 /  (CD45.2 ) 
recipients. (A and B) 6 or 1 wk after transfer, LN cells were collected and 
labeled for CD45.1, CD4, and CD25, and CD45.1  CD4  cells were gated 
and analyzed by FACS for the presence of converted CD4  CD25  cells. 
(A) Figure represents typical dot-plot and B shows the percentage of 
CD45.1  CD4  CD25  cells in individual mice. LN and spleen cells were 
pooled and sorted for CD45.1  CD4  CD25  cells (C) 6 or (D) 1 wk after 
transfer into B7.1/B7.2    mice by high speed sorter and tested for regu-
latory function in vitro or (E) Foxp3 expression by real-time PCR (see legend 
to Fig. 1 for details). For the regulatory function assay, 12,000 freshly har-
vested CD4  CD25  cells (Responder cells) were purified and cocultured at 
a 1:2 (regulatory/responder) ratio with either freshly harvested CD4  
CD25  cells (Control) or CD45.1  CD4  CD25  (Converted) cells in the 
presence of irradiated spleen cells (APC) and anti-CD3 for 3 d. *, a signifi-
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mice, suggesting that CD4  CD25  cells can survive compa-
rably for at least 1 wk in the presence or absence of B7 co-
stimulation. To confirm that CD4  CD25  cells fail to con-
vert in the absence of B7 costimulation, CD45.1  CD4 
CD25  cells were transferred into B6 or B7.1/B7.2 /  mice
and CD45.1  CD4  CD25  cells were analyzed or sorted 1
wk later. As described above for 6 wk, 2–4% of the trans-
ferred CD45.1  cells expressed CD25 (Fig. 7 A, bottom, and
B, right). However, as also described for 6 wk, these con-
verted CD25  cells were unable to suppress proliferation
(Fig. 7 D). Furthermore, these cells did not express Foxp3
mRNA (Fig. 7 E) or high levels of either GITR or CTLA-4
(Fig. S3, available at http://www.jem.org/cgi/content/full/
jem.20041201/DC1), the markers characteristic of conven-
tional CD4  CD25  regulatory cells. Because CD4  CD25 
cells can survive for at least 1 wk in the absence of B7 co-
stimulation, these results strongly suggested that the failure to
find converted CD4  CD25  regulatory cells after transfer
into B7.1/B7.2 /  mice is because these cells fail to convert
in the absence of B7 costimulation. In the aggregate, these
results indicate that B7 costimulation is an absolute require-
ment for conversion of CD4   CD25   cells into CD4 
CD25  regulatory cells.
DISCUSSION
Regulation by CD4  CD25  T cells is an important compo-
nent of peripheral tolerance that is responsible for control-
ling autoreactive T cells in normal individuals. Where these
cells originate and how they are maintained in the periphery
are unknown. We show here for the first time that periph-
eral CD4  CD25  T cells can convert in vivo into a CD4 
CD25  regulatory T cell phenotype spontaneously in a natu-
ral environment. The converted cells appear to be function-
ally and phenotypically indistinguishable from naturally oc-
curring CD4  CD25  regulatory T cells. The converted
cells are anergic, suppress the proliferation of CD4  CD25 
responder T cells in vitro (although not through the produc-
tion of TGF  or IL-10), and express high levels of Foxp3
mRNA as well as a phenotypic profile of surface markers in-
cluding GITR, CTLA-4, and CD103 at levels that are com-
parable to that found in naturally occurring CD4  CD25 
regulatory T cells.
Previous studies using various model systems have found
that CD4  CD25  cells can be induced to express CD25 and
exhibit regulatory properties both in vivo and in vitro. The
in vivo studies, however, used model systems consisting of
TCR transgenic mice that express high affinity clonotypic
TCR and supraphysiological amounts of specific nonself
peptide either administered exogenously or expressed en-
dogenously as a transgene (6, 7). Thorstenson and Khoruts
(17) have shown that a percentage of OVA-specific TCR
transgenic CD4  CD25  cells from RAG /  mice adop-
tively transferred into normal mice could be induced to ex-
press CD25 and develop regulatory function after either i.v.
or oral administration of a tolerizing dose of purified OVA
peptide (7). Along the same lines, Apostolou et al. (6) found
that a small percentage of CD4  CD25  cells also converted
to a CD25  phenotype after transfer of influenza hema-
glutinin-specific TCR transgenic CD4  CD25  cells on a
RAG /  background into transgenic mice that expressed the
hemaglutinin peptide under the control of the immunoglob-
ulin   promoter. However, in the latter model, both the
converted CD25  and the transferred CD25  cells exhibited
regulatory properties, suggesting that under these conditions
strong TCR signaling and/or aberrant expression of antigen
by atypical APCs may induce cells that are anergic and sup-
pressive, but does not necessarily reflect what occurs under
normal conditions, i.e., with T cells expressing a normal
TCR repertoire and presentation of small amounts of self-
peptide. Thusly, although both of these studies provided
data that suggested that CD4  CD25  cells could convert to
a CD4  CD25  regulatory T cell phenotype, conversion oc-
curred under somewhat extraordinary conditions. These
studies did not address the issue of whether a naturally oc-
curring population of CD4  CD25  cells exists that under
natural conditions has the same potential to convert to a
CD4  CD25  regulatory T cell phenotype. Recent studies
have found that both murine and human CD4  CD25  cells
can be induced in vitro to develop into CD4  CD25  T
cells that exhibit many of the characteristics found in CD4 
CD25  regulatory T cells including anergy, suppression of
responder cell proliferation, expression of Foxp3, and in the
case of murine cells, the ability to prevent allergen-induced
asthma (27, 28). Taken together, these data suggest that at
least some types of CD4  CD25  cells have the inherent
ability to convert to a CD4  CD25  regulatory T cell phe-
notype, and indeed the results of this study confirm that this
can happen spontaneously in a natural environment.
Several approaches were used in this study to rule out the
possibility that the apparent conversion from CD4  CD25 
cells into CD4  CD25  regulatory cells was simply the result
of expansion and/or selective survival of a trace population of
CD4  CD25  cells inadvertently transferred along with the
CD4   CD25   cells. First, CFSE-labeled CD45.1   CD4 
CD25  cells were transferred into nonirradiated CD45.2  re-
cipients and the nonproliferating CFSEhi  CD45.1  CD4 
CD25  cells were found to exhibit regulatory function, sug-
gesting that in the absence of expansion, conversion still oc-
curs. Furthermore, analysis of absolute numbers of CD45.1 
CD4  CD25  cells in both nonirradiated and sublethally irra-
diated mice that had received either 10    106 CD45.1 
CD4  CD25  cells or 106 CD45.1  CD4  CD25  cells dem-
onstrated that it would be virtually impossible for the prog-
eny of a trace population of 30,000 CD4  CD25  cells (i.e.,
0.3% contamination) to account for the numbers of these
cells found either 1 or 6 wk after transfer of CD4  CD25 
cells (Table S1). With regard to selective survival of the trace
population of CD4  CD25  cells, analysis of absolute num-
bers of either CD4  CD25  cells or CD4  CD25  cells re-
covered after injection of known numbers of the respective
populations indicated that the CD4  CD25  cells do not typ-
ically exhibit greater survival tendencies than CD4  CD25 JEM VOL. 201, January 3, 2005 135
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cells (in fact, the reverse might be true; Table S1). These data
effectively ruled out the possibility that the CD4  CD25 
cells found after transfer of CD4  CD25  cells are the result
of expansion of a trace population of CD4  CD25  cells and/
or their selective survival and support the premise that CD4 
CD25  cells can convert into CD4  CD25  regulatory cells.
Lymphocytes placed in a lymphopenic environment will
undergo homeostatic proliferation (29). Because a percent-
age of the transferred CD4   CD25   cells up-regulated
CD25, which was indicative of some sort of “activation”
event, we tested whether homeostatic proliferation was a re-
quirement for conversion of CD4  CD25  cells to a CD4 
CD25  regulatory T cell phenotype by injecting CD4 
CD25  cells into nonirradiated recipients. Although the per-
centage and total number of CD4  donor cells recovered in
sublethally irradiated mice were much larger than in mice
that received no radiation treatment, CD4  CD25  cells
could still convert to a CD4  CD25  regulatory T cell phe-
notype in the absence of homeostatic proliferation (i.e., in
nonirradiated mice). These data suggest that although trans-
ferred CD4  CD25  T cells can, they apparently do not
need to undergo homeostatic proliferation to convert to a
CD4  CD25  regulatory T cell phenotype. Furthermore,
we have shown that converted CD4  CD25  cells were able
to suppress proliferation of responder cells at low regulatory/
responder T cell ratios, whereas freshly harvested CD4 
CD25  regulatory T cells could not. These data suggested
that the converted CD4  CD25  cells, similar to the natu-
rally occurring CD4  CD25  cells (18), became more potent
suppressors in vitro after undergoing homeostatic prolifera-
tion in vivo, which is another indication that the converted
CD4  CD25  cells are similar to naturally occurring CD4 
CD25  regulatory cells.
Some, but not all, of the requirements for the conversion
of CD4  CD25  T cells into a CD4  CD25  regulatory T
cell phenotype are similar to the requirements for the devel-
opment of naturally occurring CD4  CD25  regulatory T
cells. Both CTLA-4 and CD28 are involved in the develop-
ment of CD4  CD25  regulatory T cells, as this population
of cells is dramatically decreased in mice deficient for either
of these molecules (14, 17, 24–26). More importantly, B7
appears to be required for the peripheral maintenance of this
population (24–26). Similar to the requirements for develop-
ment of naturally occurring CD4  CD25  regulatory T cells,
the conversion of CD4  CD25  T cells into CD4  CD25 
regulatory T cells also requires costimulation via B7. On the
other hand, most naturally occurring CD4  CD25  regula-
tory T cell development does appear to occur in the thymus
(3, 30), whereas conversion of CD4  CD25  T cells to a
CD4  CD25  regulatory T cell phenotype does not require
the presence of the thymus. These data suggest that the
mechanism of induction might be similar for both popula-
tions, whereas the site of induction may differ; the thymus
might be necessary for naturally occurring CD4  CD25 
regulatory T cell development, and a peripheral (i.e., an ex-
trathymic) site appears to be sufficient for conversion of
CD4  CD25  T cells. These data corroborate those found in
another study, which showed that CD4  CD25  T cells can
be converted to a CD4  CD25  regulatory phenotype after
exposure to exogenous antigen in the periphery (31).
To date, nothing is known about the CD4  CD25  T
cells that convert to a CD4  CD25  regulatory T cell phe-
notype. For example, it is not clear whether the CD4 
CD25  cells that convert to a CD4  CD25  regulatory T
cell phenotype represent a population of cells that was origi-
nally CD25  and/or whether they represent a population
that arises de novo in the periphery either from a population
that is predestined to become CD4  CD25  regulatory cells,
or from cells that have the potential to also become effector
cells. These issues warrant further study.
In conclusion, normal CD4  CD25  cells have the po-
tential to convert spontaneously in the periphery into CD4 
CD25  regulatory T cells that are physically and functionally
indistinguishable from naturally occurring CD4  CD25 
regulatory T cells. This conversion occurs under natural (ei-
ther lymphopenic or nonlymphopenic) conditions, i.e., us-
ing a normal T cell repertoire and in the presence of the nat-
ural array of endogenous antigens. The conversion of CD4 
CD25  cells into CD4  CD25  cells in a normal environ-
ment may contribute significantly to the maintenance and,
therefore, homeostasis of the peripheral CD4  CD25  regu-
latory T cell population. A defect in this conversion process
could result in a peripheral CD4  CD25  regulatory cell
population of insufficient size to control the autoreactive T
cells that escape negative selection and have the potential to
mediate autoimmune disease.
MATERIALS AND METHODS
Mice. 6–8-wk-old female and male C57BL/6 (CD45.2 ), B.6SJL-
PtprcaPep3b/BoyJ (CD45.1 ), and B7.1/B7.2 knockout mice were purchased
from The Jackson Laboratory and maintained in the animal facility at the Uni-
versity of Louisville. Animals were maintained under the guidelines stipulated
by the University of Louisville Institutional Animal Care and Use Committee.
FACS analysis and antibodies. The following reagents were used:
FITC–, PE–, and PerCP–anti-CD4; FITC–, PE–, and biotinylated anti-
CD25; FITC–anti-CD45RB, anti-CD62L, and anti-CD45.1; PE–anti-
CD103, anti–CTLA-4, and anti-CD45.1; biotinylated CD45.2 antibodies
and FITC-, PE-, PERCP-, and APC-labeled streptavidin; anti-CD3 anti-
body (BD Biosciences) and PE–anti-GITR, TGF , IL-10, and isotype anti-
bodies (R&D Systems); and CFSE (Molecular Probes). For FACS analysis,
cells were incubated with antibodies and staining buffer (Dulbecco’s PBS,
0.1% BSA, and 0.01% Na2 azide) for 15 min and then washed and analyzed
on a FACScan or FACSCalibur (Becton Dickinson).
Tracking adoptively transferred cells. The CD45 isotype was used as a
marker to track cells in the recipients. Lymphocytes were obtained from
LNs and spleen and processed in HBSS supplemented with 2% FCS (Hy-
clone). T cells from spleens were enriched using T cell enrichment columns
and then along with LN cells, applied to CD4 cell–enrichment columns
(R&D Systems). The recovered CD4-enriched cells were labeled with PE–
anti-CD25 antibody and incubated with anti–PE beads (Miltenyi Biotec),
and then passed through a magnetic column according to the manufac-
turer’s instructions. The recovered cells were then labeled with anti-CD4
antibody and sorted for either CD4  CD25  or CD4  CD25  T cells using
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contamination of sorted CD4  CD25  T cells was consistently  0.3% (Fig.
1 A). 10   106 sorted CD4  CD25  T cells from B.6SJL-PtprcaPep3b/BoyJ
mice (CD45.1 ) were then injected i.v. into either nonirradiated or sub-
lethally irradiated (550 rads) C57BL/6 (CD45.2 ) mice. For some experi-
ments, CD45.1  CD4  CD25  cells were labeled in complete media with
20  M CFSE for 30 min at 37 C and then washed three times. And for
some experiments, adult mice (6–8 wk of age) were thymectomized before
receiving the i.v. injection of cells. Blood was collected weekly, and LN,
spleen, and thymus (when available) were collected either 1 or 6 wk after
injection. Cells were then either analyzed by FACS or sorted for use in in
vitro assays or for analysis of Foxp3 expression. Absolute cell numbers were
determined by direct cell counts and flow cytometric analysis.
In vitro proliferation assay. T cells from spleens were enriched using T
cell–enrichment columns and then along with LN cells, applied to CD4
cell–enrichment columns (R&D Systems). CD4-enriched cells were labeled
with anti-CD45.1, anti-CD4, and anti-CD25 and sorted by a high speed
cell sorter. CD4  CD25  T cells were evaluated for their ability to suppress
proliferation by coculture with CD4  CD25  responder T cells (either
25,000 or 12,000), irradiated spleen cells (105 cells) as APCs, and 10  g/ml
anti-CD3 antibody. (The regulatory/responder ratios that were tested in
these assays were dependent on the number of converted CD4  CD25 
cells recovered, i.e., under some experimental conditions, very few trans-
ferred cells were recovered.) For some experiments, anti-TGF , anti–IL-
10, or 10–50  g/ml of isotype antibody was added to the cultures. For the
anergy experiments, 25,000 cells to be tested were cultured with irradiated
spleen cells and anti-CD3 antibody as described above. Cells were cultured
in complete media (RPMI 1640, 10% heat-inactivated FCS, 2 mM gluta-
mine, 10 mM Hepes, 100 U/ml penicillin G sodium, 100  g/ml strepto-
mycin sulfate, and 10 5 M 2-mercaptoethanol) at 37 C and 5% CO2 for 3 d.
0.5  Ci [H3]thymidine was added for the last 18 h. Cells were harvested
and [H3]thymidine incorporation was measured by scintillation counter.
Real-time PCR. CD4  CD25  T cells were sorted to  98% purity. To-
tal RNA was extracted using the Picopure RNA isolation kit (Arcturus)
and reverse transcribed using the TaqMan reverse transcriptase kit (Applied
Biosystems). The cDNA was amplified in duplicate by real-time PCR using
the SYBR Green PCR kit (Applied Biosystems) with primers for GAPDH
and Foxp3. Foxp3 mRNA levels were normalized relative to GAPDH
mRNA expression. Data are presented as the fold-change relative to CD4 
CD25  T cells. Primer pairs were designed using software provided by Ap-
plied Biosystems and synthesized and purified by HPLC by Integrated DNA
Technologies. Primer pairs were as follows: Foxp3, 5 -CCCACCTACAG-
GCCCTTCTC-3   and  5 -GGCATGGGCATCCACAGT-3 ; GAPDH,
5 -GGAGCGAGACCCCACTAACA-3   and 5 -ACATACTCAGCAC-
CGGCCTC-3 .
Statistical analyses. Data were subjected to analyses by either the stu-
dent’s t test or ANOVA and the Tukey-Kramer multiple comparisons test.
All experiments were performed at least twice, and the majority were per-
formed three or more times with similar results.
Online Supplemental Material. Spleen cells from mice that have re-
ceived CD4  CD25  cells were labeled with anti-CD45.1, CD4, and
CD25 antibodies and analyzed for the presence of converted CD4  CD25 
cells by FACS (Fig. S1). 25,000 converted CD4  CD25  cells were tested
for their ability to proliferate in response to stimulation in vitro (Fig. S2).
Converted CD4  CD25  cells harvested from B7.1/B7.2 /  mice 1 wk af-
ter transfer were labeled with anti-CD45.1, CD4, CD25, and either anti-
GITR, CTLA-4, CD103, CD62L, or CD45RB antibodies and analyzed by
FACS (Fig. S3). Total numbers of cells were calculated by using cell counts
of LN and spleen and the results of FACS analysis (Table S1). Figs. S1–S3
and Table S1 are available at http://www.jem.org/cgi/content/full/jem.
20041201/DC1.
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